Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors. It is conducting Phase 1, Phase 1/2, Phase 2a, and Phase 2b clinical trials in various indications, such as aging-related frailty, alzheimer's disease, and hypoplastic left heart syndrome. Longeveron Inc. was incorporated in 2014 and is headquartered in Miami, Florida.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-11-08 |
2024-09 |
-0.53 |
N/A |
N/A |
N/A |
2024-08-14 |
2024-06 |
-1.03 |
-1.83 |
-0.8 |
-77.67% |
2024-05-14 |
2024-03 |
-2.01 |
N/A |
N/A |
N/A |
2024-05-14 |
2024-03 |
-2.01 |
-1.61 |
0.4 |
19.90% |
2024-02-27 |
2023-12 |
-2.1 |
N/A |
N/A |
N/A |
2024-02-27 |
2023-12 |
-2.1 |
-2.5 |
-0.4 |
-19.05% |
Date |
Firm |
Action |
From |
To |
2023-05-15 |
EF Hutton |
Upgrade |
Buy |
Buy |
2023-05-08 |
EF Hutton |
Upgrade |
|
Buy |
2023-03-26 |
EF Hutton |
Upgrade |
|
Buy |
2023-01-09 |
EF Hutton |
Upgrade |
|
Buy |
2022-03-23 |
Maxim Group |
Upgrade |
|
Buy |
2022-01-04 |
EF Hutton |
Upgrade |
|
Buy |
Date |
Name |
Relation |
Quantity |
Description |
2024-08-14 |
AGAFONOVA NATALIYA |
Officer |
163.13K |
Stock Award(Grant) |
2024-08-14 |
BALUCH KHOSO |
Director |
38.38K |
Stock Award(Grant) |
2024-08-14 |
HARE JOSHUA M |
Officer, Director and Beneficial Owner |
727.05K |
Stock Award(Grant) |
2024-08-14 |
HARE NEIL E |
Director |
30.25K |
Stock Award(Grant) |
2024-08-14 |
HASHAD MOHAMED WA'EL AHMED |
Chief Executive Officer |
90.37K |
Stock Award(Grant) |
2024-05-09 |
KENDER RICHARD N |
Director |
16.00K |
Stock Award(Grant) |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Vanguard Group Inc |
184.35K |
623.09K |
2.92% |
2023-06-29 |
Blackrock Inc. |
112.32K |
379.64K |
1.78% |
2023-06-29 |
Creative Planning |
109.32K |
369.51K |
1.73% |
2023-06-29 |
Yakira Capital Management, Inc. |
85.00K |
287.30K |
1.35% |
2023-06-29 |
Alpine Global Management, LLC |
75.00K |
253.50K |
1.19% |
2023-06-29 |
Boothbay Fund Management, LLC |
75.00K |
253.50K |
1.19% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Vanguard Total Stock Market Index Fund |
118.12K |
399.23K |
1.87% |
2023-06-29 |
Vanguard Extended Market Index Fund |
65.09K |
220.00K |
1.03% |
2023-05-30 |
Fidelity Extended Market Index Fund |
18.61K |
55.09K |
0.29% |
2023-08-30 |
iShares Micro Cap ETF |
10.92K |
30.70K |
0.17% |
2023-05-30 |
Fidelity Series Total Market Index Fund |
6.41K |
18.96K |
0.10% |
2023-05-30 |
Fidelity NASDAQ Composite Index Fund |
5.00K |
14.80K |
0.08% |
Split |
Date |
1 : 10 |
2024-03-27 |